What Microdosing GLP-1s Achieves Fewer side-effects: Starting lower might reduce incidence/severity of nausea, vomiting, GI distress
Each targets a distinct mechanism of skin aging, collagen synthesis, wound healing, or telomere maintenance, giving geroscience researchers a well-characterized toolkit for studying biological aging processes at the molecular level
RIBBON-1: Randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer
In contrast, GLP-1RAs provide prolonged systemic effects, making them well-suited for managing chronic conditions like T2D and obesity